TP53 rs121912612: Understanding the p.R156H Variant
The TP53 rs121912612 variant, also known as p.R156H, is a rare genetic alteration located in the TP53 gene. It has been studied for its potential association with cancer predisposition, though its clinical significance remains a subject of ongoing scientific investigation.
What each genotype means
Typical TP53 function
This genotype represents the common, wild-type sequence for this position in the TP53 gene. It is associated with standard tumor suppressor protein function as observed in the general population.
This is the most common genotype found in the vast majority of the human population.
Hypomorphic TP53 variant
This genotype, also known as p.R156H, is a rare variant that has been observed in families with cancer histories, though its clinical significance is debated. Research indicates it may be a hypomorphic mutation, meaning it retains some, but not all, normal protein function, and it has been downgraded by some laboratories from pathogenic to a variant of uncertain significance. You should discuss these findings with a genetic counselor or physician to understand how this relates to your personal and family health history.
This genotype is very rare and is not typically found in the general population.
Rare TP53 variant
This genotype represents the homozygous state for the p.R156H variant. Evidence regarding the biological impact of this specific variant is conflicting, with some studies suggesting it behaves similarly to the wild-type protein in certain cellular assays while others suggest partial loss of function. Because this is a rare finding, its clinical implications remain uncertain and should be reviewed with a medical professional.
This genotype is extremely rare and is not observed in the general population.
What is the rs121912612 Variant?
The variant rs121912612, commonly referred to as p.R156H or c.467G>A, is a specific change in the DNA sequence of the TP53 gene. In genetic terms, this is a missense mutation where the amino acid arginine is replaced by histidine at position 156 of the protein. This variant is situated within the DNA-binding domain of the TP53 protein, a region critical for the protein's ability to regulate gene expression. Because this domain is essential for the protein's function, researchers have long scrutinized variants in this area to understand how they might impact cellular health. While it has been observed in various clinical settings, its classification has shifted over time as more data has become available, leading many expert panels to currently categorize it as a variant of uncertain significance rather than a definitively pathogenic mutation.
The Role of the TP53 Gene
The TP53 gene provides instructions for making a protein called tumor protein p53, often described as the 'guardian of the genome.' This protein acts as a tumor suppressor, meaning it helps prevent cells from growing and dividing too rapidly or in an uncontrolled way. When DNA damage occurs within a cell, the p53 protein helps determine whether the cell should repair the damage or undergo a programmed cell death process known as apoptosis. By maintaining genomic stability, p53 plays a vital role in preventing the development of tumors. Because of its central importance, inherited mutations in TP53 are famously associated with Li-Fraumeni syndrome, a condition that significantly increases the risk of developing various types of cancer at an early age. Understanding how specific variants like p.R156H affect this protein's function is a major focus of cancer genetics.
Research and Clinical Evidence
Research into the p.R156H variant has produced mixed findings, which is why it is currently classified as having uncertain clinical significance. Some studies have suggested that the variant might be hypomorphic, meaning it retains some, but not all, of the normal function of the wild-type protein. In laboratory experiments, the p.R156H protein has shown the ability to induce apoptosis and suppress cell growth in certain conditions, appearing similar to the normal protein. However, other studies have noted decreased protein expression and reduced activation of downstream targets like p21 in human cells. Because of these conflicting results and the fact that it has been identified in individuals who do not meet the classic clinical criteria for Li-Fraumeni syndrome, experts have cautioned against using this variant alone to make definitive clinical diagnoses. It is often studied in the context of reduced penetrance, where the presence of the variant does not always lead to the expected clinical outcome.
Population Frequency and Interpretation
The rs121912612 variant is considered very rare in the general population. Because of its rarity, large-scale population databases often contain limited information regarding its distribution across different ancestral groups. When a variant is this uncommon, it is difficult for researchers to establish strong statistical associations with specific health outcomes. Consequently, the presence of this variant in an individual's genetic profile does not provide a clear-cut answer regarding their health risks. It is important to recognize that genetic testing results can be complex and that the interpretation of variants like p.R156H may change as scientific knowledge evolves. If you have received information about this variant from a genetic test, it is essential to discuss the findings with a qualified healthcare provider or a genetic counselor who can interpret the results within the context of your personal and family medical history.
What You Can Do With This Information
If you or a family member have been identified as a carrier of the rs121912612 variant, the most important step is to consult with a medical professional. Because the clinical significance of this variant is currently uncertain, it should not be used as a standalone basis for medical decision-making or as a definitive diagnosis for any condition. A genetic counselor can help you understand the limitations of current research and how this variant might—or might not—relate to your specific health situation. They can also help you determine if further clinical evaluation or surveillance is appropriate based on your overall health profile. Never make changes to your medical care or health management based on genetic data without first speaking to your doctor. Genetic information is only one piece of a much larger puzzle that includes your environment, lifestyle, and family history.
How common is this variant?
The rs121912612 variant is very rare in the general population, with limited data available across different ancestral groups to establish precise frequency statistics.
Frequently asked questions
Is rs121912612 a cause of Li-Fraumeni syndrome?
While the TP53 gene is associated with Li-Fraumeni syndrome, the p.R156H variant is currently classified as a variant of uncertain significance. It does not definitively confirm a diagnosis of the syndrome.
What does 'variant of uncertain significance' mean?
This term means that there is not enough scientific evidence at this time to determine whether the variant is benign or if it contributes to a disease. Research is ongoing to clarify its role.
Should I be worried if I have this variant?
Genetic findings should always be discussed with a healthcare professional. Because the significance of this variant is uncertain, it is not a clear indicator of health risk and should be interpreted by a specialist.
Can I use this information to change my medical care?
No, you should never change your medical care based on genetic results without consulting your doctor. Only a clinician can determine if any follow-up or surveillance is necessary based on your full medical history.
Sources & further reading
Educational information only, last refreshed 10/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121912612?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TP53
This variant is a hypomorphic germline mutation in the TP53 gene associated with a spectrum of cancer predisposition and incomplete penetrance.
This variant is a well-established polymorphism in the TP53 gene often studied for its potential role in cancer susceptibility and cellular response to stress.
A recognized Li-Fraumeni syndrome pathogenic missense variant (p.Arg248Gln) altering sequence-specific DNA binding and predisposing to various early-onset tumors.
Functional codon 72 polymorphism (Arg72Pro) affecting apoptotic capability and associated with differential susceptibility to multiple cancer types.
This variant is a hypomorphic allele associated with incomplete penetrance and late-onset cancer predisposition.
Functional 3' UTR polyadenylation signal polymorphism altering TP53 transcription termination, showing population-specific baseline carrier frequencies across global groups.